UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000053659
Receipt number R000061228
Scientific Title Prospective observational study to analyze the association between the pathogenesis of perforated peptic ulcers and HLA.
Date of disclosure of the study information 2024/02/26
Last modified on 2024/02/20 14:03:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

HLA and perforated peptic ulcer

Acronym

HLA and perforated peptic ulcer

Scientific Title

Prospective observational study to analyze the association between the pathogenesis of perforated peptic ulcers and HLA.

Scientific Title:Acronym

Prospective observational study to analyze the association between the pathogenesis of perforated peptic ulcers and HLA.

Region

Japan


Condition

Condition

Peptic ulcer

Classification by specialty

Gastroenterology Gastrointestinal surgery

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

1. Why do some patients with ulcers perforate and others not?
2. HLA may associate the pathogenesis of perforated ulcers.
3. Exploratory research of predictors for perforated ulcers.

Basic objectives2

Others

Basic objectives -Others

Clinical characteristics, HLA, HLA-relevant peptides, subsequent gastric cancer in the remnant stomach

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

Clinical risk factors between peptic ulcer patients who perforated and not and HLA.

Key secondary outcomes

Ulcer recurrence, subsequent gastric cancer and multiple primary malignancy.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Perforated peptic ulcers and non-perforated peptic ulcers whose HLA was measured, including cases in which prior treatment and diagnosis (endoscopy, etc.) were confirmed.

Key exclusion criteria

NP

Target sample size

500


Research contact person

Name of lead principal investigator

1st name Toshi
Middle name
Last name Mitomi

Organization

Tokai University

Division name

Department of Surgery

Zip code

259-1193

Address

Bohseidai, Isehara, Kanagawa, Japan.

TEL

0463-96-6163

Email

ogoshik@gmail.com


Public contact

Name of contact person

1st name Kyoji
Middle name
Last name Ogoshi

Organization

Tokai University

Division name

Department of Surgery

Zip code

259-1193

Address

Bohseidai, Isehara, Kanagawa, Japan.

TEL

0463-96-6163

Homepage URL


Email

ogoshik@gmail.com


Sponsor or person

Institute

Study Group for Gastroenterological Disease

Institute

Department

Personal name



Funding Source

Organization

Study Group for Gastroenterological Disease

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Study Group for Gastroenterological Disease

Address

4-2-28 Kudan-kita, Chiyoda-ku, Tokyo, 102-0073, Japan

Tel

03-6261-0245

Email

office@ace-enterprise.net


Secondary IDs

Secondary IDs

YES

Study ID_1

11R-127,128

Org. issuing International ID_1

Tokai University

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

See https://www.jstage.jst.go.jp/article/acrt/31/2/31_42/_article/-char/ja


Other administrative information

Date of disclosure of the study information

2024 Year 02 Month 26 Day


Related information

URL releasing protocol

https://www.jstage.jst.go.jp/article/acrt/31/2/31_42/_article/-char/ja

Publication of results

Published


Result

URL related to results and publications

https://www.jstage.jst.go.jp/article/acrt/31/2/31_42/_article/-char/ja

Number of participants that the trial has enrolled

422

Results

1. Patients with (n = 303) and without (n = 119) PPU recruited from our member hospitals and more likely to have duodenal ulcers, young, consume alcohol, and smoke. There was no significant difference in sex and ulcer recurrence. Perforated peptic ulcer patients and patients who underwent vagotomy decreased risks of cancer development.
2. Patients harboring HLA-Cw1 and -Cw7 and their heterozygotes protected against PPU development, whereas HLA-Cw3 reduced cancer development.

Results date posted

2024 Year 02 Month 20 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results

2023 Year 07 Month 28 Day

Baseline Characteristics

See https://www.jstage.jst.go.jp/article/acrt/31/2/31_42/_article/-char/ja

Participant flow

See https://www.jstage.jst.go.jp/article/acrt/31/2/31_42/_article/-char/ja

Adverse events

NP

Outcome measures

See https://www.jstage.jst.go.jp/article/acrt/31/2/31_42/_article/-char/ja

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

1977 Year 12 Month 01 Day

Date of IRB

1977 Year 12 Month 01 Day

Anticipated trial start date

1977 Year 12 Month 14 Day

Last follow-up date

2007 Year 01 Month 15 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The principles of this study outlined in the Declaration of Helsinki were followed. As T. Mitomi passed away, an e-mail address of the principal investigator is that of K. Ogoshi.


Management information

Registered date

2024 Year 02 Month 20 Day

Last modified on

2024 Year 02 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061228


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2024/02/20 潰瘍UMIN登録提出.xlsx